ALDX logo

Aldeyra Therapeutics, Inc. (ALDX)

Profile

Full Name

Aldeyra Therapeutics, Inc.

Ticker

NASDAQ: ALDX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 2, 2014

Indexes

Not included

Website

http://www.aldeyra.com

Employees

8

Key Details

Price

$5.11(+0.29%)

Market cap

$305.77M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.94(-46.88% YoY)

PE ratio

-

Next earnings date

Aug 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.11
    ALDX price is $5.11

    30-Day Relative Volume

    0.86
    ALDX 30-day relative volume is 0.86

    Price Performance

    Price Today change

    +0.29%
    ALDX price is up +0.29% today

    Price YTD change

    +2.3%
    ALDX price is up +2.3% since January 1st

    Price 1-year change

    +29.24%
    ALDX price is up +29.24% year-on-year

    Price 3-year change

    +1.29%
    ALDX price is up +1.29% over the past 3 years

    Price Range

    Price All-time high

    $16.70
    ALDX price is currently -69.43% below its historical high of $16.70

    Price 3-year low

    $1.14
    ALDX price is currently +347.81% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $305.77M
    ALDX market capitalization is $305.77 million

    Market cap 3-year change

    +4.06%
    ALDX market capitalization is up +4.06% over the past 3 years

    Market cap All-time high

    $747.48M
    ALDX market capitalization is currently -59.09% below its historical high of $747.48 million

    Market cap sector rank

    58.45%
    ALDX market capitalization is higher than 58.45% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.8%
    ALDX shares outstanding is up +0.8% year-on-year

    Shares Outstanding 3-Year Change

    +2.73%
    ALDX shares outstanding is up +2.73% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.34
    ALDX beta is 1.34

    200-day SMA

    $4.55
    ALDX price is currently +12.28% above its 200-day simple moving average

    50-day SMA

    $3.60
    ALDX price is currently +41.73% above its 50-day simple moving average

    RSI

    62.32
    ALDX 14-day relative strength index is 62.32

    Volume

    0.86
    ALDX 30-day relative volume is 0.86

    ATR

    $0.32
    ALDX average true range is $0.32

    10-day Historical Volatility

    61.70%
    ALDX 10-day historical volatility is 61.70%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    ALDX annual revenue value is unknown

    Revenue Analysts estimate

    $27.72M
    ALDX annual revenue is currently equal to the consensus analysts' forecast

    Revenue 1-year change

    -
    ALDX annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    ALDX annual revenue is unknown

    EPS

    EPS

    -$0.94
    ALDX annual earnings per share is -$0.94

    EPS Analysts estimate

    -$0.68
    ALDX annual earnings per share is currently +37.73% higher than the consensus analysts' forecast

    EPS 1-year change

    -46.88%
    ALDX annual earnings per share is down -46.88% year-on-year

    EPS Sector rank

    57.34%
    ALDX annual earnings per share is higher than 57.34% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ALDX annual gross profit value is unknown

    Gross margin

    -
    ALDX annual gross profit margin value is unknown

    Operating profit

    -$60.12M
    ALDX annual operating income is -$60.12 million

    Operating margin

    -
    ALDX annual operating profit margin value is unknown

    Net income

    -$55.85M
    ALDX annual net profit is -$55.85 million

    Net margin

    -
    ALDX annual net profit margin value is unknown

    Expenses

    Total expenses

    $60.12M
    ALDX annual total expenses is $60.12 million

    Operating expenses

    $60.12M
    ALDX annual total operating expenses is $60.12 million

    Cost of goods sold

    -
    ALDX annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $11.89M
    ALDX annual SGA is $11.89 million

    Depreciation and amortization

    $249.60K
    ALDX annual depreciation & amortization is $249.60 thousand

    Interest expense

    $1.93M
    ALDX annual interest expense is $1.93 million

    Income tax

    -
    ALDX annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$53.93M
    ALDX annual earnings before interest & taxes is -$53.93 million

    EBITDA

    -$53.68M
    ALDX annual EBITDA is -$53.68 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $104.61M
    ALDX annual total assets is $104.61 million

    Non current assets

    $534.20K
    ALDX annual long term assets is $534.20 thousand

    Current assets

    $104.07M
    ALDX annual total current assets is $104.07 million

    Cash and cash equivalents

    $54.53M
    ALDX annual cash & cash equivalents is $54.53 million

    Accounts receivable

    -
    ALDX annual accounts receivable value is unknown

    Inventory

    -
    ALDX annual inventory value is unknown

    Liabilities

    Total liabilities

    $33.60M
    ALDX annual total liabilities is $33.60 million

    Long term liabilities

    $15.00M
    ALDX annual total long term liabilities is $15.00 million

    Current liabilities

    $18.60M
    ALDX annual total current liabilities is $18.60 million

    Accounts payable

    $180.50K
    ALDX annual accounts payable is $180.50 thousand

    Debt

    Total debt

    $15.30M
    ALDX annual total debt is $15.30 million

    Total debt 1-year change

    -2.26%
    ALDX annual total debt is down -2.26% year-on-year

    Long term debt

    $15.00M
    ALDX annual long term debt is $15.00 million

    Short term debt

    $303.00K
    ALDX annual short term debt is $303.00 thousand

    Equity & Capital

    Shareholders equity

    $71.00M
    ALDX annual stockholders equity is $71.00 million

    Book value

    $71.00M
    ALDX annual book value is $71.00 million

    Retained earnings

    -$450.11M
    ALDX annual retained earnings is -$450.11 million

    Working capital

    $85.47M
    ALDX annual working capital is $85.47 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$43.21M
    ALDX annual cash flow from operations is -$43.21 million

    Cash from operations 1-year change

    -42.48%
    ALDX annual cash flow from operations is down -42.48% year-on-year

    Cash from investing

    -$44.92M
    ALDX annual cash flow from investing activities is -$44.92 million

    Cash from investing 1-year change

    -249.72%
    ALDX annual cash flow from investing activities is down -249.72% year-on-year

    Cash from financing

    -$171.40K
    ALDX annual cash flow from financing activities is -$171.40 thousand

    Cash from financing 1-year change

    +86.51%
    ALDX annual cash flow from financing activities is up +86.51% year-on-year

    CAPEX

    CAPEX

    -
    ALDX annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    ALDX annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$43.21M
    ALDX annual free cash flow is -$43.21 million

    Free cash flow 1-year change

    -42.48%
    ALDX annual free cash flow is down -42.48% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ALDX annual gross profit margin value is unknown

    Operating margin

    -
    ALDX annual operating profit margin value is unknown

    Net margin

    -
    ALDX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -53.39%
    ALDX annual return on assets is -53.39%

    ROE

    -78.66%
    ALDX annual return on equity is -78.66%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ALDX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ALDX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    4.81
    ALDX price to book ratio is 4.81

    PB ratio Sector rank

    78.83%
    ALDX price to book ratio is higher than 78.83% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ALDX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ALDX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $270.98M
    ALDX enterprise value is $270.98 million

    Enterprise value Sector rank

    57.35%
    ALDX enterprise value is higher than 57.35% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -4.88
    ALDX EV/EBITDA is -4.88

    EV/EBITDA Sector rank

    24.85%
    ALDX EV/EBITDA is higher than 24.85% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.59
    ALDX annual current ratio is 5.59

    Quick ratio

    -
    ALDX annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.22
    ALDX annual debt to equity ratio is 0.22

    Interest coverage ratio

    -28.00
    ALDX annual interest coverage ratio is -28.00

    Risk & Stability

    Piotroski F-Score

    -
    ALDX piotroski f-score value is unknown

    Altman Z-Score

    -
    ALDX altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    May 19, 25 HC Wainwright & Co.
    Buy
    Apr 7, 25 BTIG
    Buy
    Apr 4, 25 HC Wainwright & Co.
    Buy
    Mar 3, 25 HC Wainwright & Co.
    Buy
    Aug 9, 24 HC Wainwright & Co.
    Buy
    Aug 2, 24 HC Wainwright & Co.
    Buy
    May 6, 24 Oppenheimer
    Outperform
    May 6, 24 HC Wainwright & Co.
    Buy
    Apr 3, 24 Oppenheimer
    Outperform
    Oct 17, 23 Oppenheimer
    Perform

    Institutional Ownership

    Screeners with ALDX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Aldeyra Therapeutics, Inc.?
    • Does Aldeyra Therapeutics, Inc. pay dividends?
    • What sector is Aldeyra Therapeutics, Inc. in?
    • What industry is Aldeyra Therapeutics, Inc. in?
    • What country is Aldeyra Therapeutics, Inc. based in?
    • When did Aldeyra Therapeutics, Inc. go public?
    • Is Aldeyra Therapeutics, Inc. in the S&P 500?
    • Is Aldeyra Therapeutics, Inc. in the NASDAQ 100?
    • Is Aldeyra Therapeutics, Inc. in the Dow Jones?
    • When was Aldeyra Therapeutics, Inc.'s last earnings report?
    • When does Aldeyra Therapeutics, Inc. report earnings?

    What is the ticker symbol for Aldeyra Therapeutics, Inc.?

    The ticker symbol for Aldeyra Therapeutics, Inc. is NASDAQ:ALDX

    Does Aldeyra Therapeutics, Inc. pay dividends?

    No, Aldeyra Therapeutics, Inc. does not pay dividends

    What sector is Aldeyra Therapeutics, Inc. in?

    Aldeyra Therapeutics, Inc. is in the Healthcare sector

    What industry is Aldeyra Therapeutics, Inc. in?

    Aldeyra Therapeutics, Inc. is in the Biotechnology industry

    What country is Aldeyra Therapeutics, Inc. based in?

    Aldeyra Therapeutics, Inc. is headquartered in United States

    When did Aldeyra Therapeutics, Inc. go public?

    Aldeyra Therapeutics, Inc.'s initial public offering (IPO) was on May 2, 2014

    Is Aldeyra Therapeutics, Inc. in the S&P 500?

    No, Aldeyra Therapeutics, Inc. is not included in the S&P 500 index

    Is Aldeyra Therapeutics, Inc. in the NASDAQ 100?

    No, Aldeyra Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Aldeyra Therapeutics, Inc. in the Dow Jones?

    No, Aldeyra Therapeutics, Inc. is not included in the Dow Jones index

    When was Aldeyra Therapeutics, Inc.'s last earnings report?

    Aldeyra Therapeutics, Inc.'s most recent earnings report was on May 14, 2025

    When does Aldeyra Therapeutics, Inc. report earnings?

    The next expected earnings date for Aldeyra Therapeutics, Inc. is August 1, 2025
    On this page